HC Wainwright & Co. Reiterates Buy on Precigen, Maintains $14 Price Target

Benzinga · 2d ago
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Precigen (NASDAQ:PGEN) with a Buy and maintains $14 price target.